Here is the top of page
This is the navigation link for moving toward in this page.
ABSTRAL® is the novel, rapidly-disintegrating, sublingual (under the tongue) formulation of fentanyl, a well-established opioid used for the management of episodes of breakthrough pain experienced by cancer patients who are already receiving opioid analgesics for chronic pain.
Marketed by Kyowa Hakko Kirin in
Marketed by Kyowa Kirin International in
Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, UK, Ireland